Related Experiment Video
Updated: May 10, 2026

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
Serotonin transporter gene: will epigenetics prove less depressing than genetics?
Psychosomatic Medicine
|June 22, 2013
Summary
Environmental factors influence depression risk through epigenetic changes in the serotonin transporter gene. Methylation differences, not gene variations, correlated with depressive symptoms in identical twins, suggesting epigenetic effects are key.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- The serotonin transporter gene (5-HTTLPR) polymorphism's link to depression is debated, with inconsistent findings.
- Environmental factors, particularly stress, are hypothesized to interact with genetic predisposition for depression.
- Epigenetic modifications, such as DNA methylation, offer a potential mechanism for environmental influence on gene expression, independent of genetic variations.
Discussion:
- This study investigated epigenetic differences in monozygotic twins to disentangle genetic and environmental influences on depression.
- Researchers compared intrapair differences in depressive symptoms with differences in DNA methylation at the serotonin transporter gene promoter.
- Findings indicate a correlation between methylation status and depressive symptoms, suggesting an environmental origin for these epigenetic changes.
Key Insights:
- Depressive symptoms were associated with higher methylation levels in the serotonin transporter gene promoter region.
- These epigenetic effects were found to be independent of the 5-HTTLPR genetic polymorphism.
- Methylation differences, originating from environmental factors, play a significant role in depression vulnerability.
Outlook:
- The results highlight the importance of epigenetics in understanding depression.
- Further genome-wide studies are encouraged to explore the broader contribution of epigenetic effects to depression.
- This research opens new avenues for therapeutic interventions targeting epigenetic modifications.
Related Concept Videos
Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Epistasis Analysis
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
